Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:MRSH
NYSE:MRSHInsurance

Is Marsh & McLennan (MRSH) Offering Value After Recent Share Price Weakness?

If you have been wondering whether Marsh & McLennan Companies at around US$173 a share is a fair deal or not, this article walks through what the current price might be implying about value. The stock has slipped around 0.8% over the last week, 0.5% over the last month and 5.1% year to date, with a 22.9% decline over the past year contrasted against 5.4% and 47.1% returns over the past 3 and 5 years. Recent news around Marsh & McLennan Companies has focused on the business as a major...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

Did Earnings Miss and Temu Scrutiny Just Shift PDD Holdings' (PDD) Investment Narrative?

PDD Holdings’ Q4 2025 results, released in late March, showed earnings per share of 17.69 and revenue of CN¥123.91 billion, both below analyst expectations, amid pressure from competition, economic softness, and heavy supply chain investments. At the same time, the group is confronting heightened regulatory scrutiny in China and abroad, including investigations and potential changes to import duty rules that could affect its Temu platform and broader operations. We’ll now examine how this...
OM:NMAN
OM:NMANBuilding

Global Undervalued Small Caps With Insider Buying

In a week marked by geopolitical tensions and energy market volatility, global markets saw significant movements, with major U.S. stock indexes finishing higher despite mixed economic signals. Smaller-cap indexes also posted solid gains, indicating potential opportunities in the small-cap sector as investors navigate through these uncertain times. In such a dynamic environment, identifying undervalued small-cap stocks can be particularly appealing to investors looking for growth potential...
SHSE:688582
SHSE:688582Electronic

3 High Growth Tech Stocks With Promising Global Potential

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite have shown resilience with significant gains, reflecting a broader sentiment of cautious optimism amid geopolitical uncertainties. In this environment, identifying high growth tech stocks with promising global potential requires a focus on companies that demonstrate robust adaptability and innovation to thrive despite fluctuating economic conditions.
KOSDAQ:A357780
KOSDAQ:A357780Chemicals

Global Stocks That May Be Priced Below Estimated Value

In a global market characterized by geopolitical tensions and energy volatility, investors are navigating through mixed signals in economic indicators and stock performances. As indices like the Nasdaq Composite and S&P 500 experience notable gains amid these uncertainties, the search for stocks that may be priced below their estimated value becomes increasingly relevant. Identifying such stocks often involves looking at companies with strong fundamentals that can weather current market...
PSE:ICT
PSE:ICTInfrastructure

Global Growth Companies With High Insider Ownership

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite and S&P 500 have shown resilience with notable gains. Against this backdrop, investors often seek growth companies where high insider ownership can signal confidence in a company's future prospects.
SZSE:300324
SZSE:300324Aerospace & Defense

Global Penny Stocks To Watch In April 2026

Global markets have been navigating through a volatile period, with energy market fluctuations and geopolitical tensions in the Middle East capturing investor attention. Despite these challenges, major indices like the Nasdaq Composite and S&P 500 have posted gains, suggesting resilience amid uncertainty. In such an environment, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities for investors seeking affordability alongside growth potential. While...
SHSE:688690
SHSE:688690Chemicals

Global's Undiscovered Gems Featuring Three Promising Stocks

In recent weeks, global markets have been navigating a complex landscape marked by geopolitical tensions in the Middle East and fluctuating energy prices. Despite these challenges, smaller-cap indexes like the S&P MidCap 400 and Russell 2000 have shown resilience with solid gains, suggesting that opportunities may exist for discerning investors willing to explore beyond the usual suspects. In this environment, identifying promising stocks often involves looking for companies with strong...
SHSE:603889
SHSE:603889Luxury

Global Dividend Stocks To Watch In April 2026

As global markets navigate the complexities of Middle East tensions and energy market volatility, investors are paying close attention to economic indicators and geopolitical developments that influence stock performance. Amidst this backdrop, dividend stocks continue to attract interest for their potential to provide steady income streams, especially in times of uncertainty. A good dividend stock often exhibits strong fundamentals and a history of reliable payouts, making it an appealing...
TSE:7649
TSE:7649Consumer Retailing

Sugi Holdings (TSE:7649) Margin Improvement Tests Bearish Earnings Forecast Narrative

Sugi HoldingsLtd (TSE:7649) has just released its FY 2026 numbers, with fourth quarter revenue of ¥260.2 billion and basic EPS of ¥51.47, capping a trailing twelve month period where revenue reached ¥1.0 trillion and basic EPS came in at ¥248.56. Over recent quarters, revenue has moved from ¥243.4 billion in Q4 FY 2025 to ¥260.2 billion in Q4 FY 2026, while basic EPS shifted from ¥36.60 to ¥51.47. This sets up a story where improving net profit margins and higher trailing earnings are the key...
NYSE:SXI
NYSE:SXIMachinery

A Look At Standex International (SXI) Valuation After Revenue Beat And Growth Outlook Update

Revenue beat and growth outlook put Standex International (SXI) in focus Standex International (SXI) is on investors’ radar after reporting a 16.6% year-on-year revenue increase that topped analyst expectations, coupled with guidance pointing to mid to high single digit organic growth. See our latest analysis for Standex International. Alongside the guidance update, the share price has climbed 14.92% over the past 90 days and the 1-year total shareholder return is 97.44%. This indicates that...
NYSE:MCD
NYSE:MCDHospitality

McDonald’s Value 2.0 Tests Pricing Power And Leadership Shift For Investors

McDonald’s (NYSE:MCD) has launched its McValue 2.0 menu across the US, featuring an Under $3 Menu and new bundled meal deals. The company is pairing these offers with fresh pop culture collaborations, including KPop Demon Hunters themed meals. McDonald’s has also appointed new senior executives to strengthen its leadership team as affordability pressures remain in focus. For you as an investor, McDonald’s sits at the intersection of quick service dining, branding, and real estate, where...
TSE:8267
TSE:8267Consumer Retailing

Aeon (TSE:8267) Earnings Surge To ¥30 EPS Tests Bullish Margin Improvement Narrative

Aeon (TSE:8267) has just closed FY 2026 with fourth quarter revenue of ¥2.97t and basic EPS of ¥30.22, alongside trailing 12 month revenue of ¥10.72t and EPS of ¥26.87, giving investors a clear read on the latest top and bottom line profile. Over recent periods, the company has seen quarterly revenue move from ¥2.66t in FY 2025 Q4 to ¥2.56t in Q1, ¥2.62t in Q2, ¥2.56t in Q3 and ¥2.97t in Q4 of FY 2026. Basic EPS has ranged from a loss of ¥8.23 in FY 2025 Q3 to a profit of ¥30.22 most...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian Bets On AI Remix To Make Confluence A Workflow Hub

Atlassian (NasdaqGS:TEAM) has launched new AI capabilities in Confluence, including an open beta of Remix, a tool that turns static text into visual stories. The company has also introduced pre-built third party agents that connect Confluence with partner apps such as Lovable, Replit, and Gamma for automatic content transformation and workflow integration. For Atlassian, known for collaboration products like Confluence and Jira, this move pushes its core knowledge product toward a more...
NYSE:STC
NYSE:STCInsurance

A Look At Stewart Information Services (STC) Valuation After Recent Share Price Moves

Recent performance snapshot for Stewart Information Services With no single headline event driving attention, Stewart Information Services (STC) has attracted interest based on its recent share performance, including a 1.2% gain over the past day and 7.8% over the past week. See our latest analysis for Stewart Information Services. That recent upswing comes after a softer patch, with the share price showing a 4.9% decline over three months and a 6.8% decline year to date, while longer term...
LSE:GSK
LSE:GSKPharmaceuticals

GSK’s Exdensur China Approval Adds New Dimension To Valuation Debate

GSK (LSE:GSK) has received Chinese regulatory approval for Exdensur to treat chronic rhinosinusitis with nasal polyps in adults. Exdensur is described as the first ultra long acting biologic approved in China for this condition. The therapy is indicated for patients who do not respond adequately to conventional treatments. The approval follows positive Phase III trial results and provides a twice yearly treatment option. For you as an investor, this approval adds another product to GSK’s...
TSE:2918
TSE:2918Food

Warabeya Nichiyo Holdings TSE 2918 Earnings Nearly Double Challenging Cautious Profitability Narratives

Warabeya Nichiyo Holdings (TSE:2918) closed out FY 2026 with fourth quarter revenue of ¥56.1b and a basic EPS loss of ¥25.52, alongside trailing twelve month revenue of ¥233.8b and EPS of ¥307.31 that reflects earnings growth of 99.3% over the past year. Over recent periods the company has seen quarterly revenue move from ¥53.2b in FY 2025 Q4 to ¥62.1b in FY 2026 Q2, while quarterly EPS has ranged from a loss of ¥54.96 to a gain of ¥142.60. This performance provides the backdrop for reported...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

A Look At Harmony Biosciences (HRMY) Valuation After Recent Leadership Changes And Board Appointments

Harmony Biosciences Holdings (HRMY) is in focus after appointing Peter Anastasiou as Chief Operating Officer, adding Troy Ignelzi to the Board, and nominating Geno J. Germano for election at the 2026 shareholder meeting. See our latest analysis for Harmony Biosciences Holdings. The recent leadership reshuffle comes as Harmony Biosciences trades at US$29.16, with a 7 day share price return of 5.12% contrasting with a 90 day share price decline of 24.36% and a relatively flat 1 year total...
LSE:RIO
LSE:RIOMetals and Mining

A Look At Rio Tinto Group’s Valuation After Strong Recent Share Price Performance

Recent performance snapshot for Rio Tinto Group Rio Tinto Group (LSE:RIO) has attracted fresh attention after recent trading, with the share price at £72.48 and total returns of 6% over the past month and 21.1% year to date. Over the past 3 months the stock has returned 20.7%, contributing to a 1 year total return of 81.2%. Over longer periods, 3 year and 5 year total returns of 57.4% and 79.3% show how the position has evolved for existing shareholders. See our latest analysis for Rio Tinto...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Entegris (ENTG) Is Up 13.9% After Strait of Hormuz Reopens Key Chipmaking Material Flows

In early April 2026, semiconductor materials supplier Entegris benefited as the de-escalation of the U.S.-Iran conflict reopened the Strait of Hormuz, a key route for noble gases and other inputs used in chip fabrication. This development directly reinforces Entegris’ role in securing critical materials integrity for advanced semiconductor manufacturing, at a time when hedge fund interest highlights its importance in the supply chain. We’ll now examine how restored access to critical...
NYSE:ABT
NYSE:ABTMedical Equipment

How Abbott Baby Formula Verdict and Rising Litigation Risk May Reshape Abbott Laboratories' (ABT) Investment Profile

In late March 2026, a Chicago jury ordered Abbott Laboratories to pay US$53 million in compensatory damages to families alleging the company failed to adequately warn that its cow’s milk-based formula for premature infants could cause necrotizing enterocolitis, a potentially deadly bowel disease. This verdict, with punitive damages still to be determined, raises fresh questions about Abbott’s legal exposure, brand perception in infant nutrition, and the potential long-term impact on its...
TSE:3543
TSE:3543Hospitality

KOMEDA Holdings (TSE:3543) Margin Slippage Tests Steady Compounder Narrative

KOMEDA Holdings (TSE:3543) has wrapped up FY 2026 with fourth quarter revenue of ¥14.8b and basic EPS of ¥38.45, setting the tone for a year where trailing twelve month revenue reached ¥57.2b and EPS came in at ¥141.99. Over recent periods, the company has seen quarterly revenue move from ¥12.4b in FY 2025 Q4 to ¥14.8b in FY 2026 Q4, with basic EPS shifting from ¥30.47 to ¥38.45 alongside trailing twelve month net income of ¥6.5b. This puts the latest report in clear focus for anyone tracking...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly Expands Foundayo Obesity Launch As Valuation Signals Upside Potential

Eli Lilly's oral GLP-1 obesity pill Foundayo is beginning a broad U.S. launch via Amazon Pharmacy, GoodRx, Ro, Weight Watchers, and LillyDirect. The rollout uses multiple direct-to-consumer and digital health channels, with a focus on home delivery, self-pay options, and integrated clinical support. The move is intended to expand access to oral GLP-1 treatments and could influence how patients obtain and manage obesity therapies. Eli Lilly, traded as NYSE:LLY, is positioning Foundayo as a...